跳至主要内容
临床试验/ITMCTR1900002861
ITMCTR1900002861尚未招募未知

Based on the strategy of metabolomics, the key techniques of diagnosis of ovarian hypofunction and efficacy evaluation of kidney-tonifying method were studied

Jiangsu Province Hospital on Integration of Chinese and Western Medicine0 个研究点开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
21 至 49(—)
性别
Female

入选标准

  • normal group
  • 1. Aged 21-49, female;
  • 2. Menstrual color quantity and quality are normal;
  • 3. No serious damage to the heart, liver, kidney or hematopoietic system;
  • 4. Informed consent and voluntary participation.
  • Abnormal group
  • 1. Western medicine meets the diagnosis criteria of ovarian hypofunction and premature ovarian failure, while traditional Chinese medicine meets the diagnosis criteria of kidney-yang deficiency or kidney-yin deficiency.
  • 2. No serious damage to the heart, liver, kidney or hematopoietic system;
  • 3. Informed consent and voluntary participation.

排除标准

  • normal group
  • 1. Menstrual color quantity and quality were normal after drug treatment;
  • 2. Patients with obvious heart, brain, blood, neuropsychosis, endometrial cancer, ovarian cancer and other gynecological malignant tumors;
  • 3. Pregnancy or lactation;
  • 4. Drink or use drugs;
  • 5. Other treatments received within 4 weeks.
  • Abnormal group
  • 1. Congenital abnormal development of reproductive organs, or amenorrhea caused by acquired organic lesions and injuries;
  • 2. Pregnancy or lactation;
  • 3. Patients with obvious heart, brain, blood, neuropsychosis and diabetes;
  • 4. Drink or use drugs;
  • 5. Allergic to the research drugs;
  • 6. Patients with polycystic ovary syndrome;
  • 7. Patients receiving other treatment within 4 weeks.

研究者

发起方
Jiangsu Province Hospital on Integration of Chinese and Western Medicine

相似试验